We and others have previously demonstrated that in hematopoietic and GI tumor cells, modulation of Src is dependent on protein tyrosine phosphatase activity, and inhibition of these phosphatases attenuates Src-dependent cancer cell growth and metastasis [17]. Here, SRC is linked to cancer.